Research coauthored by RTI Health Solutions researchers will be presented at the 40th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID).
Comparing the public health impact of switching to pediatric 13-valent pneumococcal conjugate vaccine in the near-term and higher-valent pneumococcal conjugate vaccines in the long-term in the Netherlands. Sundaram V, Wasserman M, Waterval-Overbeek A, Beby-Heijtel AT, McDade C, Wilson M, Perdrizet J.
E-Poster Discussion Presentation (On-Site) - Abstract Number: 384
Comparing the public health impact of the pediatric 15- and 20-valent pneumococcal conjugate vaccine in Sweden. Dorange AC, Palmborg A, Perdrizet J, Sundaram V, Wasserman M, McDade C, Wilson M.
E-Poster Discussion Presentation - Abstract Number: 377
